Home/Pipeline/ZN-A-1041

ZN-A-1041

Oncology (specific type not listed)

Phase 1Active

Key Facts

Indication
Oncology (specific type not listed)
Phase
Phase 1
Status
Active
Company

About Zion Pharma

A clinical-stage Chinese biotech developing novel small molecule oncology drugs using DMPK-driven design for best-in-class and first-in-class candidates.

View full company profile

Therapeutic Areas